Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Clofarabine for relapsed/refractory LCH and non-LC histiocytosis.
Journal: Blood advances
Published: February 11, 2026
Clofarabine for relapsed/refractory Langerhans cell (LC) and non-LC histiocytosis.
Journal: Blood advances
Published: February 11, 2026
Correction: Exploring Predictive Risk Factors for Myocardial Injury in Children Treated with Anthracyclines: A Pilot Study.
Journal: Cardiovascular toxicology
Published: January 12, 2026
Exploring Predictive Risk Factors for Myocardial Injury in Children Treated with Anthracyclines: A Pilot Study.
Journal: Cardiovascular toxicology
Published: June 06, 2025
MicroRNA-34a-5p as a promising early circulating preclinical biomarker of doxorubicin-induced chronic cardiotoxicity.
Journal: Journal of applied toxicology : JAT
Published: December 12, 2021
Doxorubicin-induced delayed-onset subclinical cardiotoxicity in mice.
Journal: Journal of applied toxicology : JAT
Published: August 15, 2021
A Novel Germline TP53 Mutation in a Patient With Li-Fraumeni Syndrome: Resolving a Variant of Uncertain Significance.
Journal: Journal of pediatric hematology/oncology
Published: August 25, 2020
Thrombopoietin Receptor Agonist Use in Children: Data From the Pediatric ITP Consortium of North America ICON2 Study.
Journal: Pediatric blood & cancer
Published: January 08, 2016
Corrigendum: The genomic landscape of juvenile myelomonocytic leukemia.
Journal: Nature genetics
Published: December 30, 2015
Nutlin-3 treatment spares cisplatin-induced inhibition of bone healing while maintaining osteosarcoma toxicity.
Journal: Journal of orthopaedic research : official publication of the Orthopaedic Research Society
Published: August 24, 2015
Last Updated: 09/26/2026